Trade Mark Journal No.2026/032 7 August 2026
WO0000001918358 (5)
Office of origin: United States of America
Date of International Registration:19 March 2026
Date of designation in the UK:
19 March 2026

International priority date claimed: 17 November 2025
(United States of America)
(99501029)
- Class 5
- Pharmaceutical preparations for the treatment and prevention of diseases, namely, human metabolic diseases, human neurological diseases, human ophthalmological diseases, and human genetic diseases.
Insitro, Inc.
Representative: Abion UK Limited, The Forum, St Paul's, 33 Gutter Lane London EC2V 8AS UNITED KINGDOM